跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,729 条关于
“ABLE-22”
全部
4,729
临床试验
660
药物
299
机构
135
资讯
3,635
去年
Ferring Advances Nadofaragene Firadenovec Clinical Program in Urothelial Cancers
9个月前
Sarasota Memorial Hospital Launches Gene Therapy Trials for Bladder Cancer Treatment
去年
Real-World Data and Ongoing Trials Highlight Efficacy of Nadofaragene Firadenovec in Bladder Cancer
去年
BCG Shortage Continues to Shape Bladder Cancer Treatment Landscape Despite New Therapy Approvals
去年
Schizophrenia Treatment Targeting Cholinergic Receptors Receives FDA Approval
去年
Advancements in Gene and Cell Therapies Target Diverse Diseases
去年
FDA Issues Complete Response Letter for Astellas' IZERVAY and Accepts Aldeyra's NDA for Reproxalap
2年前
Allogene Therapeutics Pivots Strategy with Pipeline Restructuring and 22% Workforce Reduction
上个月
Fentanyl Deaths Drop 22% as Administration Expands Prevention and Enforcement Efforts
去年
Basal Cell Neoplasm Drug Pipeline Expands with 22+ Companies Developing Novel Therapies
第 1 页,共 364 页
上一页
下一页